Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
about
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphomaInterventions for mycosis fungoidesAllogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphomaInterventions for mycosis fungoidesAllogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T cell lymphomaOral retinoids and rexinoids in cutaneous T-cell lymphomasCutaneous T-cell lymphoma: 2014 update on diagnosis, risk-stratification, and managementThe optimal use of bexarotene in cutaneous T-cell lymphomaGuideline on the clinical use of apheresis procedures for the treatment of patients and collection of cellular therapy products. British Committee for Standards in Haematology.Romidepsin: in the treatment of T-cell lymphoma.The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society.Overview of alemtuzumab therapy for the treatment of T-cell lymphomas.Cutaneous T-Cell Lymphoma: A Review with a Focus on Targeted Agents.Guidelines on the use of extracorporeal photopheresisRomidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphomaThe three dimensional conformal radiotherapy for hyperkeratotic plantar mycosis fungoidesStaging and management of cutaneous T-cell lymphoma.Cutaneous T-cell lymphoma: 2016 update on diagnosis, risk-stratification, and management.Minimizing adverse side-effects of oral bexarotene in cutaneous T-cell lymphoma: an expert opinion.Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.Haematopoietic stem cell transplantation for patients with primary cutaneous T-cell lymphoma.U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients.Emerging role of epigenetic therapies in cutaneous T-cell lymphomas.Phototherapy of mycosis fungoides.Extracorporeal photopheresis: how, when, and why.Cutaneous T-cell lymphoma: 2011 update on diagnosis, risk-stratification, and management.Romidepsin in the treatment of T-cell lymphoma: profile report.Romidepsin: a guide to its clinical use in cutaneous T-cell lymphoma.Guidelines for the management of cutaneous lymphomas (2011): a consensus statement by the Japanese Skin Cancer Society - Lymphoma Study Group.U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.Romidepsin: a histone deacetylase inhibitor for refractory cutaneous T-cell lymphoma.How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma?Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature.What are the supportive and palliative care needs of patients with cutaneous T-cell lymphoma and their caregivers? A systematic review of the evidence.Prognostic factors, prognostic indices and staging in mycosis fungoides and Sézary syndrome: where are we now?Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.The utility of bexarotene in mycosis fungoides and Sézary syndrome.Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015.The discovery and development of romidepsin for the treatment of T-cell lymphoma.
P2860
Q24200183-1605F55A-6EB7-4BA2-BBC0-EA879F9A12B4Q24200749-103DA656-EDD8-46D2-9097-2B5677A4B553Q24203887-02D2D639-F53E-4746-AEFC-0D9639F2A565Q24235242-2D28DF41-5B43-4E2C-921F-E50B415D79F7Q24236260-BF6866D6-05C7-4AC8-B427-7D8972335461Q26992062-A42AE751-DA84-4EEF-9241-1E9D88A0184BQ27024076-8714D1C7-8028-4052-89E9-23EFC024F65EQ28305252-53DFEBB9-BE49-4382-A418-DE1C50C8E435Q33165774-DAC89D26-C903-4BD0-AC5D-36BB1C52BD59Q33396519-F6063D77-6341-4F12-A6E4-021F5113068CQ33625948-52B61B55-6FCC-414C-A285-6865761E09A8Q34222228-1F9A3D26-5E09-4ED4-8877-2096CC367606Q34516083-AA039682-CB40-4DEA-A94C-8FDE1F387553Q34918643-457D922A-A99B-40A2-91E8-682D38C397AAQ35186682-22776E77-2B3F-4FC3-BB0A-35D8D9FB92F8Q35422767-7F02035B-69F5-4C8F-BEA0-B1C0D9AD02FFQ36399825-3BC49D45-AAD5-403C-8A4E-8C6D4F56A3FCQ36470196-C5C71014-B83F-4D8C-A0BE-C1CF22CC9E75Q36553825-24685A39-AAB1-43D0-9704-D725693A8658Q36870654-332EB4D2-29DD-4DB0-A859-3A6DA7B63F37Q37051049-8CA81160-134E-4709-B899-1F731013E4AFQ37074253-192BC0E1-B657-4133-BC64-717222FBF104Q37315610-7AEFBDDC-DF71-46AC-B65B-F8A3AAD90363Q37810272-39885DC9-CED6-4494-BE7C-E30215DB8B9FQ37851562-5E6B8F7D-BB95-4FCC-A248-5AAAEAB82158Q37928578-014E72BD-90B0-4CF8-B49C-9A31FAE7F66CQ37944565-776094C3-B216-4ECA-96CA-FB488F76D42AQ37952288-BC4207C6-FA2A-47D8-9654-099A4F2985BEQ37953956-44AA66E3-17BA-413B-AD10-858D64194563Q38035410-9AED945C-1FDC-4166-A82C-50D9811F8F63Q38042090-563B292D-5E0C-485B-A25B-E3EF3AB2853AQ38042561-69B0DABA-030E-4C17-B7BD-7EFF5F5E56C5Q38102049-53A9AC08-59BA-4CBC-B96B-27CBB5CD72CFQ38120303-807CD436-AAD4-4A26-B278-2A6FCC161E15Q38151733-795D1136-E6AF-4E1F-B792-37E62FCC2770Q38196931-6B82A0A0-91E6-4870-B368-EB72739F9FF5Q38212880-53E33014-435F-45C8-A636-6EE497F6668BQ38354440-8584A0B5-0265-4D1A-BB06-04D69C8F69F2Q38387292-8AFAD79C-F266-40B1-8AA7-7852B179A2BCQ38713744-54BA93D7-6A6B-4943-A165-07B0C258E170
P2860
Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@en
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@nl
type
label
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@en
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@nl
prefLabel
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@en
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@nl
P2093
P2860
P1476
Joint British Association of D ...... ry cutaneous T-cell lymphomas.
@en
P2093
British Association of Dermatologists
J R Marsden
R Russell Jones
S J Whittaker
U.K. Cutaneous Lymphoma Group
P2860
P304
P356
10.1111/J.1365-2133.2003.05698.X
P407
P577
2003-12-01T00:00:00Z